Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.13.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.3.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XCF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XCCSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FK.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.21.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FP.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.92SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.42SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.35.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HV.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.8.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.45SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDRSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.43.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KV.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.16.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.39SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JD.1.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.43SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JC.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XDPSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.3.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDYSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.18.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.4.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KS.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MM.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.48.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used